Immunic, Inc. (IMUX)

Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $76.83 million. The enterprise value is $22.50 million.

Market Cap	76.83M
Enterprise Value	22.50M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Immunic has 98.65 million shares outstanding. The number of shares has increased by 50.88% in one year.

Current Share Class	98.65M
Shares Outstanding	98.65M
Shares Change (YoY)	+50.88%
Shares Change (QoQ)	+30.42%
Owned by Insiders (%)	1.76%
Owned by Institutions (%)	30.06%
Float	65.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.27
P/TBV Ratio	2.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.03.

Current Ratio	2.19
Quick Ratio	2.05
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -208.93% and return on invested capital (ROIC) is -132.35%.

Return on Equity (ROE)	-208.93%
Return on Assets (ROA)	-88.95%
Return on Invested Capital (ROIC)	-132.35%
Return on Capital Employed (ROCE)	-308.55%
Revenue Per Employee	n/a
Profits Per Employee	-$1.12M
Employee Count	91
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.19% in the last 52 weeks. The beta is 1.48, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	-37.19%
50-Day Moving Average	0.85
200-Day Moving Average	0.94
Relative Strength Index (RSI)	40.87
Average Volume (20 Days)	1,448,610

Short Selling Information

The latest short interest is 9.49 million, so 9.62% of the outstanding shares have been sold short.

Short Interest	9.49M
Short Previous Month	10.43M
Short % of Shares Out	9.62%
Short % of Float	14.54%
Short Ratio (days to cover)	6.13

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-105.27M
Pretax Income	-101.84M
Net Income	-101.84M
EBITDA	-105.10M
EBIT	-105.27M
Earnings Per Share (EPS)	-$0.94

Balance Sheet

The company has $55.31 million in cash and $979,000 in debt, giving a net cash position of $54.33 million or $0.55 per share.

Cash & Cash Equivalents	55.31M
Total Debt	979,000
Net Cash	54.33M
Net Cash Per Share	$0.55
Equity (Book Value)	33.91M
Book Value Per Share	0.34
Working Capital	32.53M

Cash Flow

In the last 12 months, operating cash flow was -$90.14 million and capital expenditures -$136,000, giving a free cash flow of -$90.28 million.

Operating Cash Flow	-90.14M
Capital Expenditures	-136,000
Free Cash Flow	-90.28M
FCF Per Share	-$0.92

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.88%
Shareholder Yield	n/a
Earnings Yield	-132.55%
FCF Yield	-117.51%

Analyst Forecast

The average price target for Immunic is $7.00, which is 798.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	798.82%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1